ConductScience.org, home

Gene883

KYAT1: kynurenine aminotransferase 1

Cite this record

ConductScience Library. KYAT1: kynurenine aminotransferase 1. Genes, record 883. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/883

FollowSave as evidenceDownload JSON
Sources
13 sources
Release
gene-search-2026-11-13-0.2.1

Gene

Symbol
KYAT1
HGNC
Name
kynurenine aminotransferase 1
HGNC
NCBI Gene ID
883
NCBI Gene
HGNC ID
HGNC:1564
HGNC
Ensembl
ENSG00000171097
NCBI Gene
Aliases
CCBL1, GTK, KAT1, KATI
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q16773Kynurenine--oxoglutarate transaminase 14229Ensembl, GeneID, HGNC

Source UniProt

Download CSV of proteins

Patents85

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 20260226448 A12026-08-06124Q16773Espacenet
US 20260199405 A12026-07-16583Q16773Espacenet
US 20260196299 A12026-07-09451Q16773Espacenet
EP 4750891 A12026-06-03124Q16773Espacenet
JP 2026004568 A2026-01-1442714Q16773Espacenet
US 20250367269 A12025-12-041Q16773Espacenet
EP 4650780 A22025-11-194125Q16773Espacenet
US 20250320254 A12025-10-164125Q16773Espacenet
JP 2025520609 A2025-07-031Q16773Espacenet
JP 2025517970 A2025-06-124125Q16773Espacenet

See all 85 patentsDownload CSV of patents

NIH grants325

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleKYAT1 papersNewest fiscal year
T32ES007015Molecular & Environmental Toxicology Predoctoral Training Program32025
I01BX005976Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease22025
P30AG072959Cleveland Alzheimers Disease Research Center22025
P30CA016672Cancer Center Support Grant22025
P30ES017885Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD)22025
P40OD010440Caenorhabditis Genetics Center22025
R01AG076448TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimer’s Disease22025
R01AG082118Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches22025
R01AG084250Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease22025
R01AG086365Protective Role of Mitochondrial CHCHD10 in Alzheimer's Disease through MAM and Mitophagy Mechanisms.22025

Source NIH's project files

See all 325 nih grantsDownload CSV of nih grants

Papers614

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
A kynurenine immune-metabolic subtype of depression defined by childhood maltreatment and IDO2: Evidence from multi-omics profiling.Psychol Med202642803521PubTator, text miningPubMed
Se-methylselenocysteine induces NRF2-ATF4 stress signaling and ferroptosis-associated remodeling in pancreatic cancer.Free Radic Biol Med202642551763PubTator, text miningPubMed
The Landscape of Disulfidptosis in Preeclampsia Reveals a Novel 5-Gene Diagnostic Signature via Machine Learning.Int J Womens Health202642369820PubTator, text miningPubMed
CO2-sensitive K+ channel traffic affects stomata and whole-plant water use.J Integr Plant Biol202642021468PubTator, text miningPubMed
Kynurenine Pathway, Nrf2 and NF-κB Cross-Regulation in the CNS: An Overview.Mol Neurobiol202641894093PubTator, text miningPubMed
Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration.Life (Basel)202641752903PubTator, text miningPubMed
Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples.Epigenomes202641718409PubTator, text miningPubMed
The Impact of Clinical Variables and Dialysis Modality on Kynurenine Pathway Enzymes Expression.Int J Mol Sci202641683738PubTator, text miningPubMed
Elevating Circulating L-Kynurenine Promotes Frailty in Aging Mice.J Cachexia Sarcopenia Muscle202641622921PubTator, text miningPubMed
Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial.JMIR Res Protoc202641592613PubTator, text miningPubMed

See all 614 papersDownload CSV of papers

None in this release

  • Drugs
  • Trials

Sources 13

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
  • USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
  • USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/883

GET https://conductscience.org/api/genes/v1/883/patents?page=2